FORX-428

· FoRx Therapeutics AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FORX-428, covering 2026-01-21 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors. [Phase 1]